|
|
2025's Stock Market Performance
|
|
2025's Stock Market Performance
|
2025's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2025.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 10/03/26.
2025's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2025 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 10/03/26.
2025's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2025 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 10/03/26.
2025's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2025 with the market capitalization, trading under 50 million U.S. dollars, as of 10/03/26.
Who are the 2025's Stock Market Losers?
KLC
-75.23%
|
|
|
Kindercare Learning Companies Inc
Personal Services Industry
KLC
-75.23%
The text outlines sections of SEC filings and addresses forward-looking statements.
|
MLTX
-75.40%
|
|
|
Moonlake Immunotherapeutics
Major Pharmaceutical Preparations Industry
MLTX
-75.40%
Moonlake Immunotherapeutics*s business model revolves around the development and commercialization of innovative immunotherapies for the treatment of diseases.
|
SG
-78.93%
|
|
|
Sweetgreen Inc
Restaurants Industry
SG
-78.93%
Sweetgreen Inc operates a fast-casual restaurant chain that focuses on serving fresh and healthy food options sourced from local farmers. Their business model revolves around offering customizable salads and grain bowls made with seasonal ingredients, promoting sustainability and community partnerships, and providing a tech-driven ordering experience through their mobile app and website. They also prioritize customer engagement by hosting events and fostering a sense of community through their various locations.
|
CMMB
-80.63%
|
|
|
Chemomab Therapeutics Ltd
Major Pharmaceutical Preparations Industry
CMMB
-80.63%
Chemomab Therapeutics Ltd is a biotechnology company focused on developing innovative treatments for fibrosis-related diseases. Their business model revolves around the research and development of therapeutic antibodies targeting specific pathways involved in fibrosis. By leveraging their scientific expertise and strategic collaborations, the company aims to ultimately bring effective and safe therapies to market, addressing the unmet medical needs of patients suffering from fibrosis.
|
XFOR
-82.27%
|
|
|
X4 Pharmaceuticals Inc
Biotechnology & Pharmaceuticals Industry
XFOR
-82.27%
X4 Pharmaceuticals Inc is a biopharmaceutical company focused on the research and development of innovative treatments for rare diseases, particularly those involving the immune system and rare genetic disorders. Their business model revolves around identifying potential drug candidates, conducting preclinical and clinical trials, and ultimately bringing these therapies to market to improve patient outcomes.
|
STI
-82.36%
|
|
|
Suntrust Banks Inc
Commercial Banks Industry
STI
-82.36%
SunTrust Banks Inc operates as a financial holding company that provides a wide range of banking and financial services to individual and corporate clients. Its business model revolves around serving customers through various channels such as branches, digital platforms, and call centers, offering services including consumer and commercial banking, mortgage lending, wealth management, and investment banking. With a focus on delivering personalized solutions and growth-oriented strategies, SunTrust aims to meet the financial needs of its clients and build long-lasting relationships.
|
SRPT
-82.66%
|
|
|
Sarepta Therapeutics Inc
Major Pharmaceutical Preparations Industry
SRPT
-82.66%
Sarepta Therapeutics Inc*s business model centers around the research, development, and commercialization of innovative genetic medicines for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD).
|
JBIO
-83.58%
|
|
|
Jade Biosciences Inc
Major Pharmaceutical Preparations Industry
JBIO
-83.58%
The company develops biologic therapies for autoimmune diseases using monoclonal antibodies.
|
RVSN
-84.86%
|
|
|
Rail Vision Ltd
Railroads Industry
RVSN
-84.86%
Rail Vision Ltd is a company with a business model focused on designing and developing advanced vision systems for the railway industry, enabling real-time monitoring and analysis of track conditions and potential hazards to improve safety and operational efficiency. They provide cutting-edge technology solutions to railway operators, leveraging computer vision and machine learning algorithms to enhance their overall performance and decision-making processes.
|
NUKK
-85.95%
|
|
|
Nukkleus Inc
Consulting Services Industry
NUKK
-85.95%
Nukkleus Inc*s business model is centered around providing technological solutions and facilitating services in the financial industry.
|
WOLF
-86.87%
|
|
|
Wolfspeed Inc
Semiconductors Industry
WOLF
-86.87%
is an innovator of wide bandgap semiconductors
|
FGL
-89.05%
|
|
|
Fidelity & Guaranty Life
Life Insurance Industry
FGL
-89.05%
Fidelity & Guaranty Life operates as an insurance holding company, primarily focused on offering annuities and life insurance products to individuals and institutions. Their business model revolves around generating revenue through the sale of these financial products, while also managing risk and ensuring long-term profitability by effectively underwriting policies and investing the premiums received. Through a combination of insurance sales, policy management, and strategic investment decisions, Fidelity & Guaranty Life aims to provide financial security and grow shareholder value.
|
WORX
-89.31%
|
|
|
Scworx Corp
Cloud Computing & Data Analytics Industry
WORX
-89.31%
Scworx Corp operates as a healthcare technology company that provides software solutions to digitize and streamline the supply chain management process for healthcare providers, manufacturers, and distributors. Their platform focuses on leveraging data analytics, artificial intelligence, and blockchain technology to enhance transparency and efficiency in inventory management and procurement within the healthcare industry.
|
JDZG
-89.34%
|
|
|
Jiade Limited
Educational Services Industry
JDZG
-89.34%
The company offers software platforms and related solutions for adult education institutions in China.
|
NAAS
-90.17%
|
|
|
Naas Technology inc
Specialty Retail Industry
NAAS
-90.17%
Naas Technology Inc is a business-to-business (B2B) company that offers a software platform for creating, managing, and automating customer processes. Their business model revolves around providing customizable solutions to businesses, enabling them to streamline their operations, enhance customer experiences, and increase operational efficiencies.
|
HUBC
-94.46%
|
|
|
Hub Cyber Security Ltd
Computer Networks Industry
HUBC
-94.46%
Hub Cyber Security Ltd*s business model focuses on providing comprehensive cybersecurity solutions and services to businesses and organizations.
|
|
54.86 %
PREV.